FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085292 [Registered on: 21/04/2025] Trial Registered Prospectively
Last Modified On: 06/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [local application]  
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Efficacy of kushthadi lepa application in the management of Dadru kushtha 
Scientific Title of Study   A randomized controlled clinical study on the role of Kushthadi lepa in the management of Dadru Kushtha with special reference to Dermatophytosis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pranav Shivaji Katkar 
Designation  BAMS PG Scholar Panchakarma 
Affiliation  LKR Ayurvedic college and Research Centre 
Address  Panchakarma OPD LKR Hospital P2 MIDC area Shendi Mal Gadhinglaj kolhapur 416502

Kolhapur
MAHARASHTRA
416502
India 
Phone  9130307014  
Fax    
Email  sanku99928@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tanuja Gaikwad 
Designation  BAMD MD KAYCHIKITSA 
Affiliation  LKR Ayurvedic college and Research Centre 
Address  Panchakarma OPD LKR Hospital P2 MIDC area Shendi Mal Gadhinglaj kolhapur 416502

Kolhapur
MAHARASHTRA
416502
India 
Phone  7588335343  
Fax    
Email  gaikwadtanuja14@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pranav Shivaji Katkar 
Designation  BAMS PG Scholar Panchakarma 
Affiliation  LKR Ayurvedic college and Research Centre 
Address  Panchakarma OPD LKR Hospital P2 MIDC area Shendi Mal Gadhinglaj kolhapur 416502

Kolhapur
MAHARASHTRA
416502
India 
Phone  9130307014  
Fax    
Email  sanku99928@gmail.com  
 
Source of Monetary or Material Support  
Late Kedari Redekar Ayurvedic college and Research centre, P2 MIDC area,shendri mal,Gadhinglaj- 416501 Kolhapur, maharashtra,India 
 
Primary Sponsor  
Name  Dr Pranav Shivaji Katkar 
Address  shaswat main road near highschool,At Post- Koulage Tal- Kagal Dist- kolhapur- 416235, maharashtra,India. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pranav Shivaji Katkar  LKR Ayurvedic college and Research centre gadhinglaj  Panchakarma OPD LKR Hospital P2 MIDC area Shendi Mal Gadhinglaj kolhapur 416502
Kolhapur
MAHARASHTRA 
9130307014

sanku99928@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
LKR Ayurvedic college and Research centre gadhinglaj  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L088||Other specified local infections of the skin and subcutaneous tissue. Ayurveda Condition: DADRU-KUSHTHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-lepa, लेप (Procedure Reference: Dravyagun vidnyan uttarard Yadavji, Procedure details: lepa i.e local application of kushthadi lepa on affected site in between 7 am to 10 am once in a day for 21 days. )
(1) Medicine Name: kushthadi lepa , Reference: charak samhita chikitsa stan kushthachikitsa adhyay 7/93, Route: Topical, Dosage Form: Lepa Churna, Dose: 3(g), Frequency: od, Duration: 21 Days
2Comparator Arm (Non Ayurveda)-Itraconazole 1% ointmentAntifungal ointment i.e itraconazole 1% used for topical application on affected site
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1-Patients having signs and symptoms of Dadru i.e kandu,pidika,mandala,raga
2- Patients with tinea corporis,tinea cruris,tinea barbae.
3- Patient willing for treatment and having lakshanas of dadru. 
 
ExclusionCriteria 
Details  1- Patients having pre-diagnised history like DM,HIV,TB.
2- Pregnant patients were excluded.
3- History of any adverse drug reaction.
4- History of angioedema.
5- Patients having any kind of chronic skin diseaselike leprosy, psoriasis.
6- Tnea unguium.tinea capitis,tinea pedis,tinea manum, tinea incognito.
7- Chronoc fungal infection more than 3 months 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Efficacy of Kushthadi lepa in the management of Dadru kushtha with special reference to Dermatophytosis  0,7th day,14th day,21th day 
 
Secondary Outcome  
Outcome  TimePoints 
To study about Kushthadi lepa
To study about Dadru kushtha  
3 weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   21/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is randomised controlled clinical study on the role of Kushthadi lepa in the management of Dadru kushtha with special reference to Dermatophytosis

Total 60 patients of age 20 to 40 of both sex will be selected and divided into 2 groups of each 30 patients i.e  A and B which are trial and control groups respectively. Then group A will be given Kushthadi lepa for local application and group B will be given intraconazole 1% oinment for local application for 21 days.
 Data will be analysed and appropriate statistical test will be applied , result will be presented.
 
Close